✦ LIBER ✦

Hepatitis B e antigen–negative patients with persistently normal alanine aminotransferase levels and hepatitis B virus DNA > 2000 IU/mL

✍ Scribed by Chia-Yen Dai; Wan-Long Chuang; Jee-Fu Huang; Ming-Lung Yu

Publisher: John Wiley and Sons
Year: 2008
Tongue: English
Weight: 57 KB
Volume: 49
Category: Article
ISSN: 0270-9139
DOI: 10.1002/hep.22723

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Hepatitis B viral factors in HBeAg-Negat

Hepatitis B viral factors in HBeAg-Negative carriers with persistently normal serum alanine aminotransferase levels

✍ Chih-Lin Lin; Li-Ying Liao; Chun-Jen Liu; Ming-Whei Yu; Pei-Jer Chen; Ming-Yang 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 159 KB 👁 1 views

Chronic hepatitis B patients with high-normal serum ALT (levels of 0.5-1؋ upper limit of normal) are still at risk of liver disease progression. We thus investigated the correlation between serum ALT level and hepatitis B viral factors in HBeAg-negative carriers with persistently normal serum ALT le

A call for attention and trials on hepat

A call for attention and trials on hepatitis B e antigen–negative, alanine aminotransferase–normal chronic hepatitis B virus infection

✍ Haitao Zhao; Ruoyu Miao 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 42 KB 👁 1 views

Efficacy of lamivudine in patients with

Efficacy of lamivudine in patients with hepatitis B e antigen–negative/hepatitis B virus DNA–positive (precore mutant) chronic hepatitis befficacy of lamivudine in patients with hepatitis B e antigen–negative/hepatitis B virus DNA–positive (precore mutant) chronic hepatitis befficacy of lamivudine in patients with hepatitis B e antigen–negative/hepatitis B virus DNA–positive (precore mutant) chronic hepatitis befficacy of lamivudine in patients with hepatitis B e antigen–negative/hepatitis B virus DNA–positive (precore mutant) chronic hepatitis BB

✍ Nicolaos C. Tassopoulos; Riccardo Volpes; Giuseppe Pastore; Jenny Heathcote; Mar 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 152 KB

This placebo controlled, double-blind study evaluated the efficacy and safety of lamivudine in patients with hepatitis B e antigen (HBeAg)-negative/hepatitis B virus (HBV) DNA-positive chronic hepatitis B. Patients were randomized to receive 100 mg lamivudine orally once daily for 52 weeks (n ‫؍‬ 60

Analysis of the Hepatitis B virus precor

Analysis of the Hepatitis B virus precore and ORF-X sequences in patients with antibody to hepatitis B e antigen with and without normal ALT levels

✍ Cabrerizo, María; Bartolomé, Javier; Iñigo, Elena R.; López-Alcorocho, Juan Manu 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 108 KB 👁 3 views

Serum samples from 20 anti-hepatitis B e antigenpositive patients with and without normal alanine aminotransferase (ALT) levels who had serum hepatitis B virus (HBV) DNA detectable only by polymerase chain reation (PCR) were examined. Viral DNA was amplified by PCR, using primers that encompassed pr